jugation is required for the excretion of bilirubin into the bile and urine (17, 18) .
Chronic unconj ugated hyperbilirubinemia theoretically may result from one or more of the following mechanisms: 1) increased production of bile pigment, 2) impaired transfer of unconjugated bilirubin from plasma into the liver cell, and 3) defective conversion of unconjugated bilirubin to bilirubin glucuronide, the major bilirubin conjugate. Each of these aspects of bilirubin metabolism was investigated in each of the 23 patients.
METHODS
Patients were selected for study upon the demonstration of chronic unconjugated hyperbilirubinemia in the absence of anemia, reticulocytosis, bilirubinuria, and hepatic or splenic enlargement. One hundred twentythree grandparents, parents, siblings, children, aunts, uncles, and first cousins were also studied.
1) Serum bilirubin concentration was estimated by the Malloy-Evelyn modification of the van den Bergh reaction (19) . In nine cases bile was obtained either by duodenal intubation or by aspiration of the gall bladder at surgery. After addition of diazotized sulphanilic acid to serum and bile, concentrations of unconjugated and conjugated dipyrrolazo pigments-pigments A and B, respectively-were estimated (20) . The proportion of pigment B present as a glucuronide was calculated after estimation of the amount converted to pigment A by alkaline or beta glucuronidase hydrolysis. Bilirubin was identified in the urine by the Fouchet reaction.
2) Studies of the production of bile pigqment. a) Hemoglobin concentration, red blood cell count, hematocrit, reticulocyte count, and erythrocyte sedimentation rate were estimated in each patient by conventional techniques, and the cellular morphology of the peripheral blood and bone marrow was examined. Osmotic fragility of erythrocytes was estimated in four cases, and a Coombs test was performed in four. b) Erythrocyte survival wvas studied in 21 patients by the Cr51-labeling technique of Mollison and Veal (21) . c) Quantitative 24-hour urinary urobilinogen excretion was estimated in each patient by the method of Watson, Schwartz, Soborov, and Bertie (22) . d) Quantitative fecal urobilinogen excre-2233 tion was estimated in 22 patients by the method of Watson and colleagues (22) on 3-day stool collections.
3) Studies of the transport of unconjugated bilirubin from plasma proteins into the liver cell. a) Serum obtained from pregnant women and newborn infants inhibits the formation of bilirubin glucuronide by rat liver slices more than it does that by rat liver homogenates (23) (24) (25) . Lathe and Walker (23) suggest that the inhibitor primarily affects the uptake of bilirubin by the liver cells. Assay of serum inhibitor factor activity was performed in each of the 23 cases by the method of Lathe and Walker (23) . b) The relative amounts of bilirubin glucuronide and 4-methyl umbelliferone (4-methyl 7-hydroxycoumarin) glucuronide formed by liver slices and homogenates from three patients and six control subjects were estimated by techniques to be described in the following section. Bilirubin and 4-methyl umbelliferone were separately suspended in the patient's serum and in pooled normal human serum, and incubated with UDPGA and liver slices and homogenates.
4) Studies of glucuronide formation. a) In vivo study of glucuronide formation was performed as follows. After a 10-hour fast, 22 of the patients, 28 members of their families, and 18 control subjects ingested 1 g of menthol, and the percentage of administered menthol excreted in the urine as menthol glucuronide during the subsequent 5 hours was estimated (26) . The test was performed in each of the 22 patients on two separate occasions.
b) In vitro assay of hepatic glucuronyl transferase activity was performed with different glucuronide receptors. When liver specimens were obtained at surgery, their ability to form bilirubin and o-aminophenol glucuronides was quantified by methods described elsewhere (15, 27) . When liver specimens weighing approximately 10 to 45 mg were obtained with either the Vim-Silverman or Menghini needle, 4-methyl umbelliferone, which is highly fluorescent, served as a glucuronide receptor. All subsequent operations were performed at -20C unless otherwise noted. The liver specimens were immedi- To evaluate further the reproducibility of the method, from two to five separate liver biopsies were obtained by aspiration at surgery in nine of the control subjects. Each specimen was separately homogenized, glucuronyl transferase activity was assayed as described, and the mean enzyme activity for each subj ect was determined (Table I ). Only three of the 34 estimations exceeded a SD of 20 units for each individual, which is half the SD observed in the control group.
5) Additional studies. a) Serum thymol turbidity, cephalin cholesterol flocculation, prothrombin time, alkaline phosphatase activity, glutamic-pyruvic transaminase activity, glutamic-oxaloacetic transaminase activity, protein electrophoresis, and concentration of cholesterol, cholesterol esters, albumin, glubulin, and iron were estimated by standard methods. Bromsulphalein retention was estimated 45 minutes after the intravenous administration of 5 mg bromsulphalein per kg of body weight. b) A biopsy of liver was obtained either at surgery or by aspiration in 22 of the patients and was stained with hematoxylin and eosin. In seven cases, liver specimens obtained by aspiration biopsy were subjected to the following staining reactions (30) : oil red orange, ATPase, acid phosphatase, alkaline phosphatase, lactic dehydrogenase, DPNH cytochrome C reductase, and 5-nucleotidase. Liver biopsy specimens from six cases were examined in the electron microscope. c) An upper gastrointestinal roentgenographic series and oral cholecystography or intra- 3) Studies of the production of bile pigment. Hematologic studies including erythrocyte survival and quantitative urinary urobilinogen excretion were normal when they were performed. Quantitative fecal urobilinogen excretion was reduced in Cases 2 through 7 to between 28 and 59 lufg per day and to within normal limits in Case 8. v4) Assay of serum inhibitor factor activity. No sera front patients inhibited the formation of di-2237 rect-reacting bilirubin by rat liver slices more than did sera from control subjects (23, 24 As indicated in Figure 1 , the anicteric father and paternal uncle of Cases 2, 4, and 17 excreted 28 and 14 per cent, respectively, of ingested menthol in the urine as menthol glucuronide in the 5 hours after ingestion. Three hours after intravenous administration of 2.0 mg bilirubin per kg of body weight, serum bilirubin concentrations were 5.2 and 4.8 mg per cent, respectively, whereas control subjects and two siblings showed less than 1.5 mg per cent under similar circumstances (38 4 -methyl umbelliferone as glucuronide receptors; d) no inhibitor of glucuronide formation was demonstrable in the liver homogenates in two cases; and e) the availability of UDPGA in specimens of liver from two of the patients appeared normal as evaluated by the ability of a boiled extract of the patients' livers to stimulate glucuronide formation by rat liver homogenates (15) .
Cases 1 through 8 differ significantly, however, from cases of the Crigler-Naj jar syndrome. Each of the observed cases of the Crigler-Najjar syndrome developed jaundice within several hours after birth and all but two died with kernicterus in the first year of life (41) (42) (43) . Serum bilirubin concentrations ranged from 20 to 45 mg-per cent. Specimens of bile obtained from the duodenum were pale yellow, and contained only traces of unconjugated bilirubin (17) . By way of contrast, in Cases 1 through 8 of this study, jaundice was first noted shortly after birth (four cases), during the first decade of life (three cases), and at age 30 (one case). Serum unconjugated bilirubin concentration ranged from 6.1 to 18.8 mg per cent. Specimens of bile in four cases had normal color and contained abundant amounts of bilirubin glucuronide, perhaps explicable on the basis of reduced, but not absent, hepatic glucuronyl transferase activity. Case 1, who had kernicterus and (lied at age 42 (32), has been considered by others as a case of the Crigler-Najjar syndrome who survived to adult life (48). This is a possibility, but the finding of bilirubin glucuronide in this patient's bile contrasts with the absence of bilirubin glucuronide described in the bile of infants with this syndrome (17) .
In the Crigler-Najjar syndrome, the deficiency in glucuronide formation appears to be transmitted by a single autosomal recessive gene (46) . The studies of the families of Cases 1, 3, and 5 through 8 were inadequate to permit speculation concerning inheritance of the observed defect in glucuronide formation. More adequate data are available in the family of Cases 2, 4, and 17-represented as III-1, 111-2, and III-4, respectively, in family. An X-chromosome-linked, abnormal genec can be excluded by the apparent transmission of the defect from father, I-1, to his sons, 11 1) Clinical observations. The four cases were men from 18 to 68 years old; jaundice was first noted at 12, 13, 26, and 60 years, and did not exceed 10 years' duration at the time of study. Each case showed jaundice limited to the sclerae. Three were asymptomatic. Case 12 periodically showed signs of congestive heart failure, and died of carcinoma of the lung 9 months after these studies were performed.
2) Serum bilirubin concentrations. These ranged initially from 1.8 to 3.4 mg per cent. After addition of diazotized sulphanilic acid to each of the sera, only pigment A was identified on paper chromatograms. Serum bilirubin concentrations fluctuated for the group, from 0.3 to 4.6 mg per cent. No clear relationship was observed between this fluctuation and coexistent illness. Case 10 was observed during an episode of influenza; serum bilirubin concentration increased from 2.1 to 4.1 mg per cent during the acute illness and returned to 2.7 mg per cent with recovery. Case 11 showed no significant change in serum bilirubin concentration before, during and after a severe viral pneumonia. Increased signs of congestive heart failure were associated with increased serum bilirubin concentrations in Case 12.
3) Studies of the production of bile pigment. Estimations of hemoglobin concentration, hematocrit, red blood cell count, reticulocyte count, and erythrocyte osmotic fragility, and study of peripheral blood morphology performed at 4-to 6-week intervals for 6 to Case 10 , and was in the high normal range in the three other cases.
4) Other studies. The results of in vitro assay of serum inhibitor factor activity, in vivo and in vitro studies of glucuronide formation, liver function tests, and radiologic examinations were normal. Histologic examinations of a liver specimen from biopsy in the light microscope were normal in each case, and an electron microscopic study was normal in Case 10.
5) Family studies. There was no history of chronic jaundice in the family members of any case. Eight parents, 13 grandparents, and 15 of 15 siblings were examined. Complete blood count, serum cephalin cholesterol flocculation, and bilirubin concentrations were normal in each.
Cases 9 through 12 have compensated hemolytic states of undetermined etiology as shown by shortened erythrocyte survival despite normal hemoglobin concentrations and reticulocyte counts. Decreased erythrocyte survival has been demonstrated in other patients with chronic unconjugated hyperbilirubinemia with normal hemoglobin concentrations and reticulocyte counts and in the absence of splenomegaly (51) . Hemolysis occurring in the presence of normal liver function is only rarely associated with striking degrees of jaundice, presumably owing to the functional reserve of the liver in bilirubin metabolism (7) . The normal liver theoretically ought to be able to excrete bile pigment resulting from the modest increase in erythrocyte destruction in these patients. Acquired but undemonstrated defects either in bilirubin transfer from plasma into the liver cells or in bilirubin conjugation are probably present in addition to increased erythrocyte destruction.
C. Patients with posthepatitic unconjugated hyperbilirubinemia (Cases [13] [14] [15] [16] 1) Clinical observations. Two cases were men. The patients' ages ranged from 19 to 21 years. At the time of study, each had had jaundice for 2 to 5 years.
None of the patients was known to have been jaundiced before the onset of acute viral hepatitis. The diagnosis of viral hepatitis was established by clinical history, appropriate laboratory tests, and morphologic study of liver biopsy specimens. Cases 13 and 14 were medical students in whom normal serum bilirubin concentrations were o0)-served approximately 1 year before the onset of hepatitis. Chronic hyperbilirubinemia persisted in each patient after other signs and symptoms of hepatitis had disappeared.
2) Serumt bilirubin concentrations. In these four cases, serum bilirubin concentrations ranged initially from 2.8 to 3.8 mg per cent. After addition of diazotized sulphanilic acid to each serum, only pigment A was identified on paper chromatograms. From six to twelve estimations of serum bilirubin concentrations were made in each patient during a 12-month period. Hyperbilirubinemia was intermittent, and concentrations in the entire group ranged from 0.4 to 4.1 mg per cent. Acute pyelonephritis in Case 16 was not associated with a significant change in the serum bilirubin concentrations before, during, and after the infection.
3) Other studies. The results of studies of bile pigment production, in vitro study of serum inhibitor factor activity, and in vivo and in vitro studies of glucuronide formation were normal in each case. The results of liver function tests were normal except for a repeatedly observed 3 16 are presumed to have developed chronic unconjugated hyperbilirubinemia after documented episodes of viral hepatitis. Although a prolonged elevation of serum bilirubin in the indirect-reacting fraction has long been recognized as a consequence of viral hepatitis (52) (53) (54) (55) (56) , the mechanism by which posthepatitic hyperbilirubinemia develops remains unclear.
D. Patients with no etiologic factors or biochemical changes to account for observed chronic unconjugated hyperbilirubinemia (Cases 17-23) 1) Clinical observations. Five of the seven patients were men. The patients' ages ranged from 17 to 48 years. Jaundice was present for 2 to 27 years at the time of study. Intermittent jaundice of the mucous membranes and sclerae was the only abnormal finding on repeated physical examinations. None of the cases gave a history suggestive of acute hepatitis. Two cases were asymptomatic. Cases 20 and 21 complained of chronic easy fatigability, weakness, headache, and postprandial nausea. Cases 22 and 23 were asymptomatic for 1 year after the onset of jaundice, when an erroneous diagnosis of chronic hepatitis was made in each case. They were treated with bed rest for approximately 4 months, and subsequently complained of chronic easy fatigability. It is my impression that the symptoms in each of these cases result from anxiety about the significance of chronic jaundice rather than from organic disease.
2) Serum bilirubin concentrations. At the time of study, these ranged from 0.7 to 2.0 mg per cent. After addition of diazotized sulphanilic acid to each serum and subsequent paper chromatography, only pigment A was demonstrated. 3) Other studies. The results of studies of bile pigment production, liver function tests, and histologic examination of liver specimens by light and electron microscopy were within normal limits. The patients' serum was not more inhibitory than normal serum to the formation of directreacting bilirubin by rat liver slices. As indicated in Table IV (33, 34) . In other studies, however, after ingestion of menthol, patients with mild chronic unconjugated hyperbilirubinemia required a longer time than normal controls to excrete menthol glucuronide in the urine, although the total amount excreted during a 6-hour period was the same in both groups (57) . The delayed excretion of menthol glucuronide suggests that some limitation in the rate of glucuronide formation may be present in these patients.
Virtually nothing is known about the mechanism by which bilirubin enters the liver cell. Sera of the 23 patients in this report did not inhibit the formation of direct-reacting bilirubin by rat liver slices more than did normal sera (Table II) In view of the finding that heterozygous Gunn rats, some adolescent and adult humans with chronic unconjugated hyperbilirubinemia, and nonjaundiced parents of children with the CriglerNajjar syndrome have defects in glucuronide formnation, any glucuronide receptor used in the in vivo study of glucuronide formation ought to be capable of differentiating these groups of humans and rats from appropriate controls.
SUM MARY
Clinical and hematologic studies, liver-function and histologic examinations, in vitro studies of serum inhibitor factor, and in vivo and in vitro studies of glucuronide formation were performed in 23 patients with chronic unconjugated hyperbilirubinemia without gross evidence of liver cell dysfunction or increased erythrocyte hemolysis. One hundred twenty-three of their family members were examined.
A deficiency in glucuronide formation activity was demonstrated in vivo and in vitro in an anicteric father of two chronically jaundiced children with a demonstrable defect in hepatic glucuronyl transferase activity. An anicteric paternal uncle demonstrated abnormal menthol and bilirubin tolerance tests. In this family, this defect appears to be transmitted as an autosomal dominant gene with incomplete penetrance and varied expressivity. 
